SCHEMBL5165849

SCHEMBL5165849

NC1CNc2ccccc2O1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 3/20 0.49
GAA P10253 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HPGD P15428 1/20 0.43
HTR1A P08908 3/20 0.40
ALOX5 P09917 1/20 0.40
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
CASR P41180 1/20 0.38
PARP1 P09874 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL517074 0.76 BRD4 (0.54) NISCHGAANPSR1HPGDHTR1A
SCHEMBL214287 0.76 NISCH (0.49) NISCHGAANPSR1HPGDHTR1A
SCHEMBL19392968 0.76 BRD4 (0.54) NISCHGAANPSR1HPGDHTR1A
SCHEMBL3966534 0.76 NISCH (0.49) NISCHGAANPSR1HPGDHTR1A
SCHEMBL28265080 0.76 NISCH (0.49) NISCHGAANPSR1HPGDHTR1A
SCHEMBL28265131 0.76 NISCH (0.49) NISCHGAANPSR1HPGDHTR1A
SCHEMBL15718086 0.76 NISCH (0.49) NISCHGAANPSR1HPGDHTR1A
SCHEMBL2638179 0.76 CASR (0.47) NISCHGAANPSR1HPGDHTR1A
SCHEMBL1756750 0.74 HPGD (0.59) NISCHHPGDKMT2A
SCHEMBL23920549 0.74 AHR (0.39) NISCHMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168128-A1 THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR DYEING PRODUCT Henkel AG & Co. KGaA (DE) 2023-04-26 EP disclosed
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2023-02-16 US disclosed
US-20220347187-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO OPERATING COMPANY LLC 2022-11-03 US disclosed
US-11230542-B2 Inhibitors of integrated stress response pathway Praxis Biotech LLC (US) 2022-01-25 US disclosed
CN-101022780-B Method for rapid hair dyeing PROCTER & GAMBLE 2014-11-05 CN disclosed
CN-102137653-B Powdered hair colouring and bleaching compositions PROCTER & GAMBLE 2014-09-10 CN disclosed
CN-101137345-B Novel hair coloring compositions for oxidative hair dyeing PROCTER & GAMBLE 2012-10-31 CN disclosed
CN-102137653-A Powdered hair colouring and bleaching compositions PROCTER & GAMBLE 2011-07-27 CN disclosed
CN-101848695-A Oxidative hair colorant compositions PROCTER & GAMBLE 2010-09-29 CN disclosed
CN-100569212-C Hair colouring compositions PROCTER & GAMBLE (US) 2009-12-16 CN disclosed
CN-1486172-A Primary intermediates for oxidative dyeing of hair P&G 2004-03-31 CN disclosed
CN-1486170-A Novel couplers for use in oxidative hair dyeing P&G 2004-03-31 CN disclosed
CN-1477948-A Novel couplers for oxidative hair dyeing P&G克莱罗尔公司 2004-02-25 CN disclosed
CN-1477947-A Primary intermediates for oxidative dyeing of hair P&G 2004-02-25 CN disclosed
CN-1474679-A Novel couplers for oxidative hair dyeing P&G 2004-02-11 CN disclosed
CN-1474681-A Novel couplers for oxidative hair dyeing P&G克莱罗尔公司 2004-02-11 CN disclosed
CN-1474680-A Novel couplers for oxidative hair dyeing P&G克莱罗尔公司 2004-02-11 CN disclosed
CN-1449276-A Primary intermediates for oxidative dyeing of hair P & G CLAIROL INC (US) 2003-10-15 CN disclosed
CN-1396819-A Novel couplers for oxidative hair dyeing P & G CLAROR INC (US) 2003-02-12 CN disclosed
US-20020166180-A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220347187-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS CDK4, CDK6, CDK8 NISCH 1407/4885GAA 2341/4885NPSR1 4775/4885
US-11230542-B2 Inhibitors of integrated stress response pathway ATF4, DDIT3, ATF1 NISCH 4069/4885GAA 2589/4885NPSR1 1399/4885
US-20230047589-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 NISCH 4069/4885GAA 2589/4885NPSR1 1399/4885
US-20020166180-A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds AHR, KRT18, HMOX2 NISCH 1606/4885GAA 4440/4885NPSR1 4616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.